Coherus Biosciences (CHRS) PT Lowered to $8 at Barclays
Tweet
Share
E-mailGet Alerts CHRS Hot Sheet
Price: $1.14 -5%
Rating Summary:
11 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Rating Summary:
11 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Join SI Premium – FREE
Barclays analyst Balaji Prasad lowered the price target on Coherus Biosciences (NASDAQ: CHRS) to $8.00 (from $13.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- JD Logistics Inc (2618:HK) (JDLGF) PT Raised to HK$18.50 at Macquarie
- JD Logistics Inc (2618:HK) (JDLGF) PT Lowered to HK$18 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
